由于医疗补助费用增加和入学人数下降, 艾利文斯医疗公司降低了2024年收入预测. Elevance Health lowers 2024 earnings forecast due to increased Medicaid costs and enrollment drop.

埃莱万斯健康公司已修改其2024年调整后的利预测,从37.20美元降至每股约33美元,主要是由于医疗补助费用增加和入学人数下降19%. Elevance Health has revised its 2024 adjusted earnings forecast down to approximately $33 per share, from $37.20, primarily due to increased Medicaid costs and a 19% drop in enrollment. 这一下降是由于国家医疗补助率与预计持续到2025年的报销费用上升之间的不匹配。 This decline is attributed to a mismatch between state Medicaid rates and rising claims costs, expected to persist into 2025. 尽管Q3的利润下降了21%,但对于医疗援助管理护理的长期增长仍然十分乐观,重点是业务效率和成员服务。 Despite a 21% decrease in Q3 profit, Elevance remains optimistic about long-term growth in Medicaid Managed Care, focusing on operational efficiencies and member service.